SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cortex (Cor) [formerly CORX]
COR 355.56+1.0%1:31 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: CoffeePot who wrote (595)10/20/1998 8:33:00 AM
From: Cage Rattler  Read Replies (1) of 1255
 
CP:

All that is well and good however there is still no indication concerning internal finance and the CFO departure. Comparing it to gold stock -- wasn't Soros also a holder of Brex?

What is not Kosher, in my opinion, is the manner in which CORX has withheld information to stock holders regarding human studies and the expected date of completion. The experiment has been designed, all variables controlled, it is underway, and they know when the completion date is scheduled. The statistical analysis will take seconds after the data is collected.

Perhaps I'm incorrect, but I'll wager the results are not up to expectancy and involved personnel are well aware of what results are forthcoming. Does it make any sense that a drug, alleged to have immediate, obvious, and "long-term" influence on memory and behavior, could be confused in a double blind study by the administrating physician -- I don't think so.

Further, I can't buy the release of exhumed press releases as random.

Ciao, Ted

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext